United States Zika Virus Vaccines Market Report 2017

Name: United States Zika Virus Vaccines Market Report 2017
Brand: QYResearch
SKU: U4736C8DEEBEN
Price: 3800 USD
Availability: InStock

January 2018 | 113 pages | ID: U4736C8DEEBEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Zika Virus Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Zika Virus Vaccines in these regions, from 2012 to 2022 (forecast).

United States Zika Virus Vaccines market competition by top manufacturers/players, with Zika Virus Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

NHI
Sanofi
GSK
Bharat.
Takeda
Inovio Pharmaceuticals
GeneOne Life Science Inc
PaxVax
Gilead Sciences Inc.
Intrexon Corp.
NewLink Genetics Corp

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

DNA Vaccine
Inactivated Vaccine
Purified Inactivated Vaccine
Table of Contents

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals
Clinics
Academic and Research
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Zika Virus Vaccines Market Report 2017

1 ZIKA VIRUS VACCINES OVERVIEW

1.1 Product Overview and Scope of Zika Virus Vaccines
1.2 Classification of Zika Virus Vaccines by Product Category
  1.2.1 United States Zika Virus Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Zika Virus Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 DNA Vaccine
  1.2.4 Inactivated Vaccine
  1.2.5 Purified Inactivated Vaccine
  1.2.6 Table of Contents
1.3 United States Zika Virus Vaccines Market by Application/End Users
  1.3.1 United States Zika Virus Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Academic and Research
  1.3.5 Others
1.4 United States Zika Virus Vaccines Market by Region
  1.4.1 United States Zika Virus Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Zika Virus Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Zika Virus Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Zika Virus Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Zika Virus Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Zika Virus Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Zika Virus Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Zika Virus Vaccines (2012-2022)
  1.5.1 United States Zika Virus Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Zika Virus Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES ZIKA VIRUS VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Zika Virus Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Zika Virus Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Zika Virus Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Zika Virus Vaccines Market Competitive Situation and Trends
  2.4.1 United States Zika Virus Vaccines Market Concentration Rate
  2.4.2 United States Zika Virus Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Zika Virus Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ZIKA VIRUS VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Zika Virus Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Zika Virus Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Zika Virus Vaccines Price by Region (2012-2017)

4 UNITED STATES ZIKA VIRUS VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Zika Virus Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Zika Virus Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Zika Virus Vaccines Price by Type (2012-2017)
4.4 United States Zika Virus Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ZIKA VIRUS VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Zika Virus Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Zika Virus Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ZIKA VIRUS VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 NHI
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Zika Virus Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 NHI Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Zika Virus Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 Zika Virus Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bharat.
  6.4.2 Zika Virus Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bharat. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Takeda
  6.5.2 Zika Virus Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Takeda Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Inovio Pharmaceuticals
  6.6.2 Zika Virus Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Inovio Pharmaceuticals Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GeneOne Life Science Inc
  6.7.2 Zika Virus Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GeneOne Life Science Inc Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 PaxVax
  6.8.2 Zika Virus Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 PaxVax Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gilead Sciences Inc.
  6.9.2 Zika Virus Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gilead Sciences Inc. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Intrexon Corp.
  6.10.2 Zika Virus Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Intrexon Corp. Zika Virus Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 NewLink Genetics Corp

7 ZIKA VIRUS VACCINES MANUFACTURING COST ANALYSIS

7.1 Zika Virus Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Zika Virus Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Zika Virus Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Zika Virus Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ZIKA VIRUS VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Zika Virus Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Zika Virus Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Zika Virus Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Zika Virus Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Zika Virus Vaccines
Figure United States Zika Virus Vaccines Market Size (MT) by Type (2012-2022)
Figure United States Zika Virus Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure DNA Vaccine Product Picture
Figure Inactivated Vaccine Product Picture
Figure Purified Inactivated Vaccine Product Picture
Figure Table of Contents Product Picture
Figure United States Zika Virus Vaccines Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Zika Virus Vaccines by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Academic and Research Examples
Table Key Downstream Customer in Academic and Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Zika Virus Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Zika Virus Vaccines Sales (MT) and Growth Rate (2012-2022)
Figure United States Zika Virus Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Zika Virus Vaccines Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Zika Virus Vaccines Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Zika Virus Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Zika Virus Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Zika Virus Vaccines Sales Share by Players/Suppliers
Figure United States Zika Virus Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Zika Virus Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Zika Virus Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Zika Virus Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Zika Virus Vaccines Revenue Share by Players/Suppliers
Table United States Market Zika Virus Vaccines Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Zika Virus Vaccines Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Zika Virus Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Zika Virus Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Zika Virus Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Zika Virus Vaccines Product Category
Table United States Zika Virus Vaccines Sales (MT) by Region (2012-2017)
Table United States Zika Virus Vaccines Sales Share by Region (2012-2017)
Figure United States Zika Virus Vaccines Sales Share by Region (2012-2017)
Figure United States Zika Virus Vaccines Sales Market Share by Region in 2016
Table United States Zika Virus Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Zika Virus Vaccines Revenue Share by Region (2012-2017)
Figure United States Zika Virus Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Zika Virus Vaccines Revenue Market Share by Region in 2016
Table United States Zika Virus Vaccines Price (USD/Kg) by Region (2012-2017)
Table United States Zika Virus Vaccines Sales (MT) by Type (2012-2017)
Table United States Zika Virus Vaccines Sales Share by Type (2012-2017)
Figure United States Zika Virus Vaccines Sales Share by Type (2012-2017)
Figure United States Zika Virus Vaccines Sales Market Share by Type in 2016
Table United States Zika Virus Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Zika Virus Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Zika Virus Vaccines by Type (2012-2017)
Figure Revenue Market Share of Zika Virus Vaccines by Type in 2016
Table United States Zika Virus Vaccines Price (USD/Kg) by Types (2012-2017)
Figure United States Zika Virus Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Zika Virus Vaccines Sales (MT) by Application (2012-2017)
Table United States Zika Virus Vaccines Sales Market Share by Application (2012-2017)
Figure United States Zika Virus Vaccines Sales Market Share by Application (2012-2017)
Figure United States Zika Virus Vaccines Sales Market Share by Application in 2016
Table United States Zika Virus Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Zika Virus Vaccines Sales Growth Rate by Application (2012-2017)
Table NHI Basic Information List
Table NHI Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure NHI Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure NHI Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure NHI Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GSK Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure GSK Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure GSK Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Bharat. Basic Information List
Table Bharat. Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bharat. Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Bharat. Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Bharat. Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Takeda Basic Information List
Table Takeda Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Takeda Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Takeda Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Inovio Pharmaceuticals Basic Information List
Table Inovio Pharmaceuticals Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Inovio Pharmaceuticals Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Inovio Pharmaceuticals Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Inovio Pharmaceuticals Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table GeneOne Life Science Inc Basic Information List
Table GeneOne Life Science Inc Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GeneOne Life Science Inc Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure GeneOne Life Science Inc Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure GeneOne Life Science Inc Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table PaxVax Basic Information List
Table PaxVax Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure PaxVax Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure PaxVax Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure PaxVax Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Inc. Basic Information List
Table Gilead Sciences Inc. Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Gilead Sciences Inc. Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Gilead Sciences Inc. Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Inc. Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table Intrexon Corp. Basic Information List
Table Intrexon Corp. Zika Virus Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Intrexon Corp. Zika Virus Vaccines Sales Growth Rate (2012-2017)
Figure Intrexon Corp. Zika Virus Vaccines Sales Market Share in United States (2012-2017)
Figure Intrexon Corp. Zika Virus Vaccines Revenue Market Share in United States (2012-2017)
Table NewLink Genetics Corp Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Zika Virus Vaccines
Figure Manufacturing Process Analysis of Zika Virus Vaccines
Figure Zika Virus Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Zika Virus Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Zika Virus Vaccines
Table Distributors/Traders List
Figure United States Zika Virus Vaccines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Zika Virus Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Zika Virus Vaccines Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Zika Virus Vaccines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume (MT) Forecast by Type in 2022
Table United States Zika Virus Vaccines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume (MT) Forecast by Application in 2022
Table United States Zika Virus Vaccines Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Zika Virus Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Zika Virus Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Zika Virus Vaccines Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports